WFM
PGEN icon

Wilmington Funds Management’s Precigen PGEN Stock Holding History

Wilmington Funds Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-27,692
Closed -$696K – 802
2014
Q1 		$696K Buy
+27,692
New +$767K 0.08% 265

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Wilmington Funds Management's PGEN Position: Q2 2014 in Review

Wilmington Funds Management sold out of Precigen (PGEN) in Q2 2014, closing a stake of 27,692 shares — an estimated $696K sold.

Wilmington Funds Management first reported a position in PGEN in Q1 2014 and held it in 1 quarter. The position peaked at $696K in Q1 2014. 107 funds tracked by Wall St. Rank hold PGEN as of Q2 2014.

  • Wilmington Funds Management reported no remaining Precigen position as of Q2 2014 after selling out during the quarter.
  • Wilmington Funds Management sold 27,692 Precigen shares in Q2 2014, an estimated $696K.
  • Wilmington Funds Management first reported a position in Precigen in Q1 2014 and held it in 1 quarter.
  • Wilmington Funds Management's Precigen position peaked at $696K in Q1 2014.
  • 107 funds tracked by Wall St. Rank held Precigen as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.